MRM Health Email Format
Biotechnology ResearchFlanders, Belgium11-50 Employees
MRM Health is a Belgian biopharmaceutical company that concentrates on discovering and developing therapeutics grounded in the human microbiome. Its approach combines live microbial strains into synergistic consortia through a proprietary optimization process, aiming to advance microbiome-based therapies. The firm operates from a microbiome research and development hub in Ghent's biotech cluster and cooperates with VIB to support microbiome analysis, ecology, host biology and disease research, along with a collaboration with DuPont Nutrition Biosciences on metabolic-disease targets. MRM Health focuses on inflammatory diseases and immune-oncology, pursuing microbiome-based therapeutics in those areas. In January 2026, it launched a Phase 2b trial of MH002 for mild-to-moderate ulcerative colitis after FDA IND clearance. The company is based in Zwijnaarde, in the Ghent region of Flanders, Belgium, and sits within a broader biotech ecosystem.